Universitätsklinikum Schleswig-Holstein (UKSH)

Erratum: August 2019 - AWMF-Registriernummer: 021-009 (Zeitschrift fur Gastroenterologie (2019) 57 (1321-1405) DOI: 10.1055/a-1015-7265) Erratum: Aktualisierte S3-Leitlinie Colitis ulcerosa (Zeitschrift fur Gastroenterologie (2019) 57 (1321-1405) DOI: 10.1055/a-1015-7265) (2019) Kucharzik T, Dignass AU, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengieβer K, et al. Journal article, Erratum P53 AND P16 EXPRESSION PROFILES IDENTIFY THREE PROGNOSTICALLY SUBGROUPS IN VULVAR CANCER: A TMA BASED STUDY BY THE AGO-CARE-TRANSLATIONAL STUDY GROUP (2019) Woelber L, Prieske K, Eulenburg C, De Gregorio N, Klapdor R, Kalder M, Braicu I, et al. Conference contribution Complex formation with monomeric α-tubulin and importin 13 fosters c-jun protein stability and is required for c-jun’s nuclear translocation and activity (2019) Kappelmann-Fenzl M, Kuphal S, Krupar R, Schadendorf D, Umansky V, Vardimon L, Hellerbrand C, Boßerhoff AK Journal article Symptoms, disease severity and treatment of adults with a new diagnosis of severe aortic stenosis (2019) Frey N, Steeds RP, Rudolph TK, Thambyrajah J, Serra A, Schulz E, Maly J, et al. Journal article Maintenance tocolysis: a reappraisal of clinical evidence (2019) Stelzl P, Kehl S, Rath W Journal article, Review article Linking pre-existing biorepositories for medical research: the PopGen 2.0 Network (2019) Lieb W, Jacobs G, Wolf A, Richter G, Gaede KI, Schwarz J, Arnold N, et al. Journal article CTCF variants in 31 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum (2019) Konrad E, Nardini N, Blyth M, Prescott K, Bouman AM, Brilstra EH, Caliebe A, et al. Conference contribution Impact of chemotherapy-induced ovarian failure (CIOF) on disease-free survival (DFS) and overall survival (OS) in young women with early breast cancer (EBC) (2019) Furlanetto J, Nekljudova V, Schneeweiss A, Thode C, Denkert C, Untch M, Bassy M, et al. Conference contribution PRECYCLE Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy (2019) Degenhardt T, Fasching P, Lueftner D, Mueller V, Thomssen C, Schem C, Witzel I, et al. Conference contribution A phase I dose-escalation and expansion trial of intratumorally administered CV8102, alone and in combination with anti-PD-1 in patients with advanced solid tumours (2019) Krauss J, Eigentler T, Schreiber J, Weishaupt C, Terheyden P, Heinzerling L, Mohr P, et al. Conference contribution